| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |